AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
Medical Devices, Pharma & Biotech BS: Genentech (POLIVY) (polivy.com)
A professionally sanitized pharma site with a low BS score due to strict regulatory requirements that mandate substance over marketing fluff. While the hero sections use soft power-phrases, the mandatory safety disclosures provide a level of forensic honesty rarely seen in other industries.
Integrate specific clinical trial identifiers (NCT numbers) directly into the H2 headings to ground claims in verifiable research. Add Person schema for the lead researchers or medical directors to bridge the authority gap. Replace generic icons with data-driven infographics showing the efficacy of the R-CHP regimen. Ensure the ‘reviews’ flagged in metadata are linked to verified third-party patient advocacy platforms or clinical registries.
The site exhibits a dual nature: headings like Plan your path with POLIVY and Every step of your first DLBCL treatment matters are low-substance emotional appeals. However, the body text is extremely dense with specific technical nouns and protocols, including the exact cocktail components (rituximab, cyclophosphamide, doxorubicin, and prednisone). The substance-to-fluff ratio is high for a patient-facing site, though it relies on repetitive regulatory blocks which artificially inflate the information volume without adding new unique data per page.
A validator checks markup; an AI audit checks comprehension. Start your free one page AI interpretation to see how your structured data is actually interpreted by LLMs.
There is virtually zero semantic drift. The homepage H1 focuses on planning a treatment path for DLBCL, and the sub-pages provide the exact functional requirements of that path: side effects, preparation checklists, and financial assistance. The messaging remains consistent across the patient and caregiver journey, moving from high-level awareness to granular medical and logistical preparation.
Stop the ROI leak caused by technical debt and strategic misalignment. Conduct an Independent Strategic Diagnosis for 1 Euro to identify high impact issues across all audit categories.
The trust_theatre_flag is triggered due to a review_count of 3 without corresponding verified proof_links_count in the metadata. While the site makes significant medical claims about being an FDA-approved treatment, it lacks direct links to peer-reviewed publications or clinical trial registry numbers (e.g., ClinicalTrials.gov) within the crawled text, relying instead on the brand authority of Genentech.
The proof density is moderate; the site provides a full list of contraindications and side effects, which serves as ‘reverse proof’ of clinical rigor. However, the ratio of marketing icons (iv bag, dollar sign) to actual data points is roughly 1:1, and the absence of specific trial data citations (like the POLARIX study) in the visible headings reduces the immediate proof density.
To review a full competitive diagnostic applied to an enterprise level technical SEO agency, including a direct comparison against Dejan, examine the complete executive audit. View the iPullRank Executive SEO Strategy Dashboard for a practical example of how perception gaps, value prop drift, and audience misalignment are surfaced in real audits.
The site follows a standard pharmaceutical ‘Patient Resource’ template, including the ubiquitous Doctor Discussion Guide and Financial Support blocks. While the drug-specific content is unique, the value proposition cliches like Every step… matters match common industry emotional mapping. It avoids extreme commodity penalties because the specific medical regimen (R-CHP) cannot be easily genericized.
Authority is derived from the Organization schema (Genentech) rather than individual experts. There is a lack of Person schema or specific named medical authorities (Chief Medical Officers or Lead Researchers), which is typical for pharma but creates a gap in personal digital footprint authority. The technical implementation is robust with clear H-tag hierarchy and structured data.
The site makes bold claims regarding its status as a first treatment for high-risk DLBCL, but it doesn’t provide the delta of performance (e.g., percentage improvement in progression-free survival) in the text snippets. The marketing tone is appropriately clinical, though the phrase ‘most out of your next doctor’s visit’ leans into service-level fluff.
Medical Devices, Pharma & Biotech BS: Genentech (POLIVY) (polivy.com)
The content perfectly matches the Pharma & Biotech category, specifically focusing on oncology and therapeutics for DLBCL. The presence of extensive safety information and detailed drug combination regimens (R-CHP) confirms the classification.
A page that loads perfectly for users can still return an empty shell to an AI crawler. Examine the Crawlability Technical Guide and understand why script free extraction is the real measure of visibility.
“The score of 25 is primarily driven by Trust Theatre flags and mandatory repetition of content. The Information Density and Semantic Coherence pillars are exceptionally strong, as the site provides exactly what a DLBCL patient needs: technical drug data and logistical prep without significant marketing drift.”